Due to the absence of people who did not attend the scheduled appointment, the Ministry of Health (Minsa) clarified the protocol to follow during vaccination against the coronavirus when the vials are left open with the doses.
Health Directive No. 133-MINSA / 2021 / DGIESP, published on Friday in the El Peruano newspaper, provides for the use of the coronavirus vaccine Exceptionally due to the non-attendance of the citizen to the immunization process.
LOOK HERE: Coronavirus Peru LIVE today May 15, 2021: Latest news, cases and figures, day 426 of the state of emergency
“In the case of having open bottles and not having the target population, it will be possible to vaccinate people of the same age or consider the next cohort in a descending way”, points out the norm.
What is the process after being vaccinated in an exceptional way?
When the dose is applied exceptionally, the vaccinator must schedule the application of the second injection and record the inoculation to record and formalize it. This is the protocol:
- The institution that carried out the indicated vaccination, under responsibility, will give your vaccination card to the immunized person, programming the date of the second dose of the corresponding vaccine.
- Likewise, health personnel should proceed with record the dose application in the system of vaccination information against COVID-19 provided by the Ministry of Health (Minsa).
Last week, the Minister of Health, Oscar Ugarte, ruled regarding the vaccines that are not used during the vaccination day. I affirm that no dose is “missed” since they are distributing and using the doses according to the number of people they summon.
LOOK HERE : Ministry of Health reports 292 deaths and 2,703 new infections of COVID-19, in the last 24 hours
“When you open the bottles where six doses come out, you have to use that bottle anyway. The bottles are being used according to the people who arrive, there is no waste. We are handling that very well. The nurses have a lot of experience with that. And therefore we are not losing vaccines”, he remarked in statements for TVPerú.
What about thawed vaccines that are unopened?
Health Directive No. 133-MINSA / 2021 / DGIESP also establishes the “reassignment of vaccines” in case doses remain available due to low demand. The section specifies that when a vaccine is thawed, it lasts for five days (with a cold chain of 2 ° C – 8 ° C) and recommends using it within that period of time.
In this case, the available vaccines must be reassigned to the people included in the prioritized group of vaccination in execution (firefighters, members of the Red Cross, cleaning personnel, security personnel, serenazgo, etc.) and who are registered in the universal standard.
The Ministry of Health specified that the remaining balances are generated because a person fails to apply the dose at the vaccination site, does not attend the scheduled appointment or has a health condition that prevents them from being immunized.
LOOK HERE: In which cases might I not be immunized against COVID-19 when I visit my vaccination center?
Currently, the doses are being applied against the COVID-19 to adults over 70 years of age in Lima and Callao; senior citizens over 80 years of age in the case of regions; people over 18 years of age with Down syndrome taking hemodialysis sessions due to kidney problems.
In the country, vaccines of Pfizer It is currently used for the immunization of the elderly and the personnel of the Armed Forces and the National Police. However, this is not the only vaccine that is applied in Peru, since in February a million doses were received from the Chinese laboratory Sinopharm, which was intended for the immunization of health personnel. To this is added, the vaccines of AstraZeneca that are applied in regions for the elderly population.
IT MAY INTEREST YOU
- More than one million 684 thousand people have already been vaccinated in our country against COVID-19
- COVID-19: What are the pending advances and gaps in the implementation of ICU beds?
- COVID-19: Government restricts application of AstraZeneca vaccine to people with thrombosis